The Anticoagulant Market is estimated to be valued at US$ 30,773.2 Mn in 2021 and is expected to exhibit a CAGR of 9.4% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:

Anticoagulants are pharmaceutical agents used to prevent blood clotting, reducing the risk of stroke, deep vein thrombosis, and pulmonary embolism. With increasing prevalence of ... Read more

Anticoagulants are widely used medications that help prevent blood clots from forming or growing larger in the body. They work by interfering with the blood coagulation system, which is responsible for blood clotting. Some common examples of anticoagulants include warfarin, apixaban, rivaroxaban, and heparin. They are commonly prescribed to patients with conditions such as atrial fibrillation, deep vein thrombosis, pulmonary embolism, and mechanical heart valves. The growing prevalence of ... Read more

The global Anticoagulant Market offers enormous potential for growth owing to rising geriatric population. Anticoagulants, also known as blood thinners, are increasingly being used to prevent blood clots in veins and arteries. These drugs play a pivotal role in reducing the risk of strokes, heart attacks, deep vein thrombosis (DVT) and pulmonary embolism (PE) for millions worldwide. The need for anticoagulants arises due to factors like atrial fibrillation, artificial heart valves, DVT and ... Read more